Simpson Healthcare Executives challenges key stakeholders in the healthcare industry to think disruptively about the future of healthcare Simpson Healthcare challenges key stakeholders in the healthcare industry to think differently as we unlock our client’s full potential to reach patients who can benefit most from their therapies. We believe that it is our responsibility to develop new and better scientific communication methods that best support the development of therapeutic solutions that will effectively improve the quality of a person’s life. We understand what it means to be human. This is why we think differently about why scientific stories of therapies matter for patients, as we aim to ensure the delivery of precision medicine: the right patient receiving the right medicine at the right time. For the past 20 years, the agency has had the opportunity to work with great healthcare clients, who strive to manage and develop disruptive therapeutic options that are most impactful for patients. The scientific expertise and disruptive thinking methods and behaviors among the elite members of Simpson Healthcare span across a broad array of many major therapeutic categories, including respiratory, oncology, cardiovascular, immunology, rare diseases, gastrointestinal, adult vaccines, and severe asthma, to name a few. Our medical and strategy teams have effectively become known as catalysts of industry innovation as we bring to bear the larger context of healthcare for our clients, aligned in our purpose, and always keeping the patient at the core of our focus. What makes Simpson Healthcare different is that we are disruptive. We have long studied how disruptive innovation has changed industries across markets and we are hands-on in applying this novel new theory of disruption, to the healthcare field. Harvard Professor, Clayton Christensen gives meaning to disruptive innovation in his book, “The Innovator’s Dilemma1”, and understands disruptive innovation to be successful when market “newcomers” beat the current “incumbents” by meeting unmet consumer needs—and this is the type of innovation that we catalyze for our healthcare clients. Many organizations across the healthcare landscape are now looking to better understand how they can harness disruptive innovation to support a better quality of life for patients as they develop their brands and strengthen their pipelines. We have seen sustainable innovations across industries become replaced by more efficient and effective options and this is the innovation intersection where healthcare stakeholders can be most impactful for patients. Disruptive innovation requires innovators to understand the whole patient journey—to find out what patients really want and then develop and deliver the more personalized, better brand. Simpson Healthcare Executives drives forward new scientific innovations and therapies for our clients that will disruptively transform healthcare worldwide and lead the industry into the future. Key stakeholders in the healthcare industry need to understand the whole story of new disruptive therapies that are entering the market, the core story of the diseases they treat, and how it will improve patients’ lives. We develop and provide the scientific communications platform for our clients to tell the story of disruption. We look forward with our healthcare clients as we dig deep into a broad array of whole disease states and therapeutic categories that are ripe for disruption and work to best to support the delivery of more personalized and precise medicine, while fulfilling the overarching goal of healthcare: to help people live better. Simpson Healthcare Executives was founded in 1998 by disruptive game changer, Kelly Simpson-Angelini, CEO and CSO; former Research Scientist at Pfizer. She is dedicated to pioneering new healthcare communication methods, including the creation of future health forums—where world experts unite to explore global datasets, shifts, health policies, and patient needs for the coming years. Kelly is a truly transformative senior leader, working to develop her people and drive forward the better brands of tomorrow. She believes that our core beliefs are tied to our purpose—this creates a strong bond among our team. As a senior executive team leader and life coach, Kelly values creating positive employee and client experiences; and actively helps her team to live their purpose. She works to get to know who her people are at their core at Simpson Healthcare—
she coaches and mentors them, striving to empower each person to find their purpose in life. She then identifies opportunities for her people to live their purpose inside and outside of Simpson Healthcare. That is a powerful way to lead an agency that pioneers disruptive change. But it works. In 2016, Kelly Simpson-Angelini was named a Women of Innovation Honoree by the Connecticut Technology Council for her entrepreneurial vision and leadership. She has since been honored in New York City by Medical Marketing and Media (MM&M) as a 2017 Healthcare Transformers- Top 10 Innovation Catalyst; and by Business Worldwide Magazine as 2017 Healthcare Industry CEO of the Year- USA and 2017 Most Innovative CEO of the Year-USA at the 2017 Business Worldwide CEO Awards. Simpson-Angelini was honored most recently this fall at the 2017 Stevie Awards for Women in Business, where she won Female Entrepreneur of the Year-Business Services: 11-2,500 Employees, Company of the Year: More than 10 Employees, and Most Innovative Company of the Year: More than 10 Employees. Kelly Simpson-Angelini currently serves as Chair of the Board of Directors at Can Do Multiple Sclerosis (MS), a non-profit organization that was founded by Olympic skier, Jimmie Huega in 1984 (formerly known as The Jimmie Huega Center for Multiple Sclerosis), with a purpose of helping people with multiple sclerosis live better. This role was expanded from her previous leadership role as a board member, as she has been heavily involved with the management of Can Do MS for quite some time. She now actively manages both the board of directors and the executive leadership teams of Can Do MS and is passionate about coaching executives at all levels to grow within their leadership roles and reach their full potential to activate their teams and most positively impact and empower patients with multiple sclerosis. Under the transformative guidance of Kelly Simpson-Angelini, our leadership team revisited the mission and vision of Simpson Healthcare a few years ago and transformed this into a purpose statement; which is rooted in our internal core belief systems, guides our teams in every moment, and is the reason why we do what we do every day at our agency. Our purpose helps us to align on the “why” we do what we do. Our purpose is to help our clients to share the scientific story of the diseases we touch and therapies discovered for all in need. We are proud to stand united with our clients as we help them to improve the quality of life for patients who will benefit most from their therapies. Simpson Healthcare is guided by five core values that all team members believe in and live by in alignment with our purpose. These may be considered to be the greatest asset to our organization because they are the pillars of our agency culture that work to bring out the best in our people. These five values guide our internal teams in our learnings, in our interactions, and build the core foundational beliefs of our culture that keep us moving forward to make our connections with each of our clients, with each other, and with the greater healthcare system both impactful and meaningful as we strive to support our clients in helping patients across the globe to live better. Our people are the link connecting the science
Published on Jul 18, 2017
ACQ5 is proud to announce to the world the winners of the ACQ5 Global Awards 2017. The 2017 ACQ5 Global Award winners represent the best o...